MASTRANGELO, ELOISE
 Distribuzione geografica
Continente #
AS - Asia 2.073
NA - Nord America 1.800
EU - Europa 773
SA - Sud America 406
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 32
OC - Oceania 8
Totale 5.265
Nazione #
US - Stati Uniti d'America 1.695
SG - Singapore 789
CN - Cina 538
IT - Italia 365
BR - Brasile 332
HK - Hong Kong 210
VN - Vietnam 207
FR - Francia 123
KR - Corea 78
BD - Bangladesh 65
NL - Olanda 54
GB - Regno Unito 52
JP - Giappone 45
CA - Canada 44
IN - India 36
DE - Germania 34
AR - Argentina 29
FI - Finlandia 26
MX - Messico 24
PL - Polonia 15
TR - Turchia 14
EC - Ecuador 13
ID - Indonesia 12
IE - Irlanda 11
IL - Israele 11
ZA - Sudafrica 11
ES - Italia 10
UA - Ucraina 10
AT - Austria 9
JM - Giamaica 9
RU - Federazione Russa 9
SE - Svezia 9
CO - Colombia 8
IQ - Iraq 8
MA - Marocco 8
PH - Filippine 7
PK - Pakistan 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
HU - Ungheria 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
HN - Honduras 5
MY - Malesia 5
PY - Paraguay 5
BO - Bolivia 4
KZ - Kazakistan 4
LT - Lituania 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
EG - Egitto 3
GT - Guatemala 3
LV - Lettonia 3
PE - Perù 3
PR - Porto Rico 3
RO - Romania 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
KE - Kenya 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
SV - El Salvador 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
SD - Sudan 1
Totale 5.090
Città #
Santa Clara 506
Singapore 478
Hefei 204
Hong Kong 203
San Jose 152
Ashburn 141
Beijing 113
Los Angeles 109
Ho Chi Minh City 79
Seoul 77
Lauterbourg 76
Brescia 60
Milan 59
Hanoi 48
Dallas 46
New York 33
Bologna 31
Tokyo 30
São Paulo 29
Rome 21
Frankfurt am Main 20
Brooklyn 15
Houston 15
Lappeenranta 15
Buffalo 13
Denver 13
Dublin 12
Montreal 12
Chicago 11
Helsinki 11
Minamishinagawa 11
Palermo 11
Rio de Janeiro 11
Brasília 10
Chennai 10
Johannesburg 10
London 10
Mexico City 10
Orem 10
Amsterdam 9
Toronto 9
Belo Horizonte 8
Caxias do Sul 8
Council Bluffs 8
Philadelphia 8
Bengaluru 7
Curitiba 7
Da Nang 7
Haiphong 7
Phoenix 7
Quito 7
Roubaix 7
Seattle 7
Shanghai 7
Atlanta 6
Biên Hòa 6
Charlotte 6
Kingston 6
Nuremberg 6
Recife 6
Stockholm 6
Tashkent 6
Thái Nguyên 6
Valenza 6
Warsaw 6
Budapest 5
Florence 5
Hải Dương 5
Nha Trang 5
Porto Alegre 5
Sydney 5
Vienna 5
Wroclaw 5
Ankara 4
Arese 4
Boardman 4
Brussels 4
Calgary 4
Columbia 4
Contagem 4
Guayaquil 4
Hortolândia 4
Louisville 4
Merone 4
Miami 4
Milwaukee 4
Naples 4
Ocala 4
Portsmouth 4
Queens 4
Ribeirão Preto 4
Sorocaba 4
St Louis 4
Turin 4
Vũng Tàu 4
Abbeville 3
Acalanes Ridge 3
Antioch 3
Baghdad 3
Bexley 3
Totale 3.047
Nome #
Notte Europea delle Ricercatrici e dei Ricercatori 2024: Grande come un virus 128
Structure-based identification of a new IAP-targeting compound that induces cancer cell death inducing NF-kappa B pathway 118
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells 116
A novel hotspot of gelsolin instability triggers an alternative mechanism of amyloid aggregation 111
Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-Mimetic 104
Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth 99
Progetto PCTO in convenzione con il Liceo Scientifico Donatelli-Pascal di Milano: Espressione della proteina TRAF2 in forma ricombinante, cristallizzazione di proteine 98
Computational and experimental characterization of NF023, a candidate anticancer compound inhibiting cIAP2/TRAF2 assembly 95
Stabilization of the retromer complex: Analysis of novel binding sites of bis-1,3-phenyl guanylhydrazone 2a to the VPS29/VPS35 interface 94
4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses 90
Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2 88
The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets 88
Modulation of guanylate cyclase activating protein 1 (Gcap1) dimeric assembly by ca2+ or mg2+: Hints to understand protein activity 85
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors 83
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis 83
Flaviviral Helicases: Structure, Function, Inhibition and Dynamics 83
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib 79
Synthesis and Characterization of Novel Mono- And Bis-Guanyl Hydrazones as Potent and Selective ASIC1 Inhibitors Able to Reduce Brain Ischemic Insult 79
High-resolution crystal structure of gelsolin domain 2 in complex with the physiological calcium ion 79
Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses 78
Gelsolin pathogenic Gly167Arg mutation promotes domain-swap dimerization of the protein 75
CHCHD4 binding affects the active site of apoptosis inducing factor (AIF): Structural determinants for allosteric regulation 73
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment 71
Head or tail? A molecular dynamic approach to the complex structure of TNF-associated factor TRAF2 70
The structure of N184K amyloidogenic variant of gelsolin highlights the role of the H-bond network for protein stability and aggregation properties 69
Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs 68
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer 67
Preparation of homo- and heterodimeric Smac mimetic compounds as apoptosis inducers 66
Ligand Binding in Allosteric Flavoproteins: Part 2. Quantitative Analysis of the Redox-Dependent Interaction of the Apoptosis-Inducing Factor (AIF) with Its Protein Partner 65
Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus. 64
Targeting the X-Linked Inhibitor of Apoptosis Protein through 4-Substituted Azabicyclo[5.3.0]alkane Smac Mimetics. Structure, Activity, and Recognition Principles 62
Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant 62
Structure-Activity Relationship of NF023 Derivatives Binding to XIAP-BIR1 62
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug 61
Crystal structure and activity of Kunjin virus NS3 helicase; Protease and helicase domain assembly in the full length NS3 protein 61
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 61
Identification of a small molecule that compromises the structural integrity of viroplasms and rotavirus double-layered particles 61
Structural snapshots of the aldol condensation reaction of the enzyme trans-o-hydroxybenzylidenepyruvate hydratase-aldolase from Pseudomonas fluorescens N3 60
An alternative non-proteolytic mechanism may underlie AGel amyloidosis 60
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 60
NF023 binding to XIAP-BIR1: Searching drugs for regulation of the NF-kappa B pathway 60
Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance 60
Comprehensive response to usutu virus following first isolation in blood donors in the friuli venezia giulia region of italy: Development of recombinant ns1-based serology and sensitivity to antiviral drugs 59
The activator of apoptosis Smac-DIABLO acts as a tetramer in solution 55
Crystal structure of a methyltransferase from a no-known-vector Flavivirus. 54
Structural bases for substrate recognition and activity in Meaban virus nucleoside-2 '-O-methyltransferase 54
Structural bases of the altered catalytic properties of a pathogenic variant of apoptosis inducing factor 53
Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor 53
Structure and functionality in flavivirus NS-proteins: Perspectives for drug design 53
Structural Basis for Bivalent Smac-Mimetics Recognition in the IAP Protein Family 51
Aryl Guanyl Hydrazones: A Viable Strategy for Designing BBB-Permeable, Neuroactive Compounds? 50
Recognition of Smac-mimetic compounds by the BIR domain of cIAP1 50
Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition. 49
Understanding the pro-survival role of AIF: structural and functional study of AIF-CHCHD4 complex 49
Preliminary crystallographic characterization of an RNA helicase from Kunjin virus 49
Delivery of Suramin as an Antiviral Agent through Liposomal Systems 49
Hemoprotein time-resolved X-ray crystallography 49
Preliminary characterization of (nucleoside-2 '-O-)-methyltransferase crystals from Meaban and Yokose flaviviruses 48
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 47
A Single Nucleoside Viral Polymerase Inhibitor Against Norovirus, Rotavirus, and Sapovirus-Induced Diarrhea 47
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. 46
Head or tail? A molecular dynamics approach to the complex structure of TNF-associated factor TRAF2 46
Ebolavirus and Marburgvirus: Insight the Filoviridae family 44
One hundred years of X-ray diffraction, 50 years of structural biology 43
Discovery of Zika Virus NS2B/NS3 Inhibitors That Prevent Mice from Life-Threatening Infection and Brain Damage 42
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 40
STructural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds 40
Structure and biochemical analysis of Kokobera virus helicase. 39
Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin 39
Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. 38
Structure-Based Inhibition of Norovirus RNA-Dependent RNA Polymerases 37
Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: Synthesis 37
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 37
Role and inhibition of GLI1 protein in cancer 36
Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase 36
Structural and functional characterization of TgpA, a critical protein for the viability of Pseudomonas aeruginosa 36
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 36
Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents 34
Ferredoxin-NADP(+) reductase from Plasmodium falciparum undergoes NADP(+)-dependent dimerization and inactivation: Functional and crystallographic analysis 34
Preliminary characterization of (nucleoside-2'-O-)-methyltransferase crystals from Meaban and Yokose flaviviruses. 34
AVERMECTINS AND MILBEMYCINS FOR THE TREATMENT, PREVENTION OR AMELIORATION OF FLAVIVIRUS INFECTION 34
Flaviviral helicase: Insights into the mechanism of action of a motor protein 34
Structural insights into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic. 33
New SMAC mimetic compounds as apoptosis inducers 33
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 33
A novel therapeutic use of an active ingredient belonging to the class of avermectins or the class of milbemycins, particularly ivermectin 32
New homo- and heterodimeric smac mimetic compounds as apoptosis inducers 32
PPNDS inhibits murine Norovirus RNA-dependent RNA-polymerase mimicking two RNA stacking bases 28
null 17
Totale 5.265
Categoria #
all - tutte 16.988
article - articoli 15.886
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202445 0 0 0 0 0 0 0 0 1 18 21 5
2024/20251.875 19 17 87 63 422 193 33 219 112 67 353 290
2025/20262.724 153 294 215 369 444 213 457 107 136 116 109 111
2026/2027621 177 121 323 0 0 0 0 0 0 0 0 0
Totale 5.265